HomeCompareLOTZ vs JNJ

LOTZ vs JNJ: Dividend Comparison 2026

LOTZ yields 1351.35% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LOTZ wins by $272583783.30M in total portfolio value
10 years
LOTZ
LOTZ
● Live price
1351.35%
Share price
$0.15
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$272583783.33M
Annual income
$237,946,152,207,798.20
Full LOTZ calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — LOTZ vs JNJ

📍 LOTZ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLOTZJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LOTZ + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LOTZ pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LOTZ
Annual income on $10K today (after 15% tax)
$114,864.86/yr
After 10yr DRIP, annual income (after tax)
$202,254,229,376,628.47/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, LOTZ beats the other by $202,254,229,372,642.47/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LOTZ + JNJ for your $10,000?

LOTZ: 50%JNJ: 50%
100% JNJ50/50100% LOTZ
Portfolio after 10yr
$136291891.68M
Annual income
$118,973,076,106,243.80/yr
Blended yield
87.29%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LOTZ
Analyst Ratings
1
Hold
Consensus: Hold
Price Target
$3.00
+1927.0% upside vs current
Range: $3.00 — $3.00
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LOTZ buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLOTZJNJ
Forward yield1351.35%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$272583783.33M$30.3K
Annual income after 10y$237,946,152,207,798.20$4,689.40
Total dividends collected$270034496.72M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$3.00$228.73

Year-by-year: LOTZ vs JNJ ($10,000, DRIP)

YearLOTZ PortfolioLOTZ Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$145,835$135,135.14$10,592$272.30+$135.2KLOTZ
2$1,997,861$1,841,817.82$11,289$357.73+$1.99MLOTZ
3$25,718,922$23,581,209.93$12,123$472.89+$25.71MLOTZ
4$311,226,018$283,706,772.10$13,141$629.86+$311.21MLOTZ
5$3,541,563,721$3,208,551,881.06$14,408$846.81+$3541.55MLOTZ
6$37,912,256,783$34,122,783,602.07$16,021$1,151.60+$37912.24MLOTZ
7$381,951,756,579$341,385,641,821.17$18,122$1,588.22+$381951.74MLOTZ
8$3,623,017,539,296$3,214,329,159,756.85$20,930$2,228.20+$3623017.52MLOTZ
9$32,371,617,873,390$28,494,989,106,343.02$24,792$3,191.91+$32371617.85MLOTZ
10$272,583,783,332,326$237,946,152,207,798.20$30,274$4,689.40+$272583783.30MLOTZ

LOTZ vs JNJ: Complete Analysis 2026

LOTZStock

CarLotz, Inc. operates as a consignment-to-retail used vehicle marketplace that provides its corporate vehicle sourcing partners and retail sellers of used vehicles. The company serves corporate vehicle sourcing partners, which include fleet leasing companies, vehicle rental companies, banks, finance companies, third-party remarketers, wholesalers, corporations managing their own fleets, and original equipment manufacturers; retail sellers of used vehicles to individuals; and retail customers. It operates 22 retail hubs throughout the Mid-Atlantic, Southeast, Southcentral, Midwest, West, and Pacific Northwest regions of the United States. The company was incorporated in 2011 and is headquartered in Richmond, Virginia. As of December 9, 2022, CarLotz, Inc. operates as a subsidiary of Shift Technologies, Inc..

Full LOTZ Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this LOTZ vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LOTZ vs SCHDLOTZ vs JEPILOTZ vs OLOTZ vs KOLOTZ vs MAINLOTZ vs ABBVLOTZ vs MRKLOTZ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.